District pharmacy authority and statutory safeguards
District of Columbia pharmacy law is its own jurisdictional body of law. Alabama rules, another state's practice act, and a nationwide federal summary cannot be relabeled as District requirements. Begin with DC Health's pharmacy-law index, the current DC Council Code, and the applicable District regulations. Professional pharmacy requirements include Title 17 provisions, while facility and drug requirements have separate sources. Treat agency guidance, statutory authority, and implementing regulations as related but distinct. A provision authorizing a service may still require certification, a written protocol, and additional conditions before the service is provided.
The Board of Pharmacy is established under DC Code section 3-1202.08. Its current composition includes pharmacists, a registered pharmacy technician, and a consumer member; older descriptions with two consumer members do not reflect the membership change effective in 2024. The statute addresses pharmacy practice, pharmaceutical detailing, and pharmacy technician practice. It also sets conditions for immunization authority, pharmacist hormonal contraceptive prescribing, and collaborative practice. A collaborative agreement must identify therapy, related tests, conditions for initiating or changing treatment, and monitoring directions. Contraceptive authority has its own certification, protocol, screening, confidential counseling, referral, and public availability requirements.
Substitution is not one undifferentiated transaction. DC Code sections 48-803.02 through 48-803.06 distinguish generically equivalent products, interchangeable biological products, and therapeutic interchange. Consider the prescriber's qualifying instructions and the purchaser's preference before substituting. The lowest purchaser cost among qualifying products in stock matters under the applicable generic-product provision; pharmacy margin is a different measure. The purchaser must be notified and have the stated opportunity to refuse before purchase. Records identify the actual substituted drug and manufacturer. Biological-product communication has specified electronic mechanisms, alternatives, timing, and exceptions; it is not the same requirement as the substitution record itself.
District prescription monitoring has separate registration, reporting, and query provisions. A completed registration does not replace a dispensing report, and a dispensing report does not replace a required query. The Code's query trigger concerns specified opioid or benzodiazepine treatment durations and refill intervals, with express exceptions. It is inaccurate to say every Schedule II through V prescription always requires the same query. Reporting also distinguishes administration, qualifying inpatient dispensing, and ordinary outpatient supply. Merely placing a prepared prescription into a pickup bin is not the dispensing event described in the reporting subsection.
Disciplinary provisions protect appropriate scope, supervision, honest records, confidentiality, informed consent, and patient safety. Actual injury is not required for every safety-related ground. Procedural hearing rights remain part of the statutory framework. This material covers selected verified District principles; it does not claim exhaustive coverage of all current operational regulations, local implementation details, renewal rules, or official MPJE calibration.